Intra-Cellular Therapies, Inc. vs 89bio, Inc., risk disclosures compared

6topics both disclose

4only Intra-Cellular Therapies, Inc.

2only 89bio, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Intra-Cellular Therapies, Inc.	89bio, Inc.
Internal Control	6	7
Ransomware	3	5
Data Residency	1	5
Material Weakness	1	5
Restatement	2	4
Business Continuity	1	1

Only Intra-Cellular Therapies, Inc.

Topic	Filings
Regulatory Investigation	4
Whistleblower Program	3
Third Party Risk Management	2
Cross Border Data Transfer	1

Only 89bio, Inc.

Topic	Filings
Consent Order	1
Enforcement Action	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Intra-Cellular Therapies, Inc. · 89bio, Inc. · All companies